Evidence map›Paper›PMID 37041448›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

EOSAL-CNV for Easy and Rapid Detection of CNVs by Fragment Analysis : EOSAL: A Fast and Reliable New Method for CNV Detection.

Francisco Lara-Hernandez, Jessica Cortez, Soraya Garcia-Sorribes, Sebastian Blesa, M Dolores Olivares, Andy S Alic, Ana-Barbara Garcia-Garcia, F Javier Chaves, Carmen Ivorra

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Francisco Lara-HernandezGenomic and Diabetes Unit, INCLIVA Biomedical Research Institute, Valencia, Spain.
Jessica CortezI+D+I Department, Sequencing Multiplex SL Serra, Valencia, Spain.
Soraya Garcia-SorribesGenomic and Diabetes Unit, INCLIVA Biomedical Research Institute, Valencia, Spain.
Sebastian BlesaGenomic and Diabetes Unit, INCLIVA Biomedical Research Institute, Valencia, Spain.
M Dolores OlivaresI+D+I Department, Sequencing Multiplex SL Serra, Valencia, Spain.
Andy S AlicI+D+I Department, Sequencing Multiplex SL Serra, Valencia, Spain.
Ana-Barbara Garcia-GarciaGenomic and Diabetes Unit, INCLIVA Biomedical Research Institute, Valencia, Spain. a.barbara.garcia@ext.uv.es.
F Javier ChavesGenomic and Diabetes Unit, INCLIVA Biomedical Research Institute, Valencia, Spain.
Carmen IvorraI+D+I Department, Sequencing Multiplex SL Serra, Valencia, Spain.
INCLIVA Health Research Institute · ESCentro de Investigación Biomédica en Red Diabetes y Enfermedades Metabólicas Asociadas · ESInstituto de Salud Carlos III · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Copy number variations (CNVs) are a type of genetic variation involving from 50 base pairs (bps) to millions of bps and, in a general point of view, can include alterations of complete chromosomes. As CNVs mean the gain or loss of DNA sequences, their detection requires specific techniques and analysis. We have developed Easy One-Step Amplification and Labeling for CNV Detection (EOSAL-CNV) by fragment analysis in a DNA sequencer. The procedure is based on a single PCR reaction for amplification and labeling of all fragments included. The protocol includes specific primers for the amplification of the regions of interest with a tail in each of the primers (one for forward and another for the reverse primers) together with primers for tail amplification. One of the primers for tail amplification is labeled with a fluorophore, allowing the amplification and labeling in the same reaction. Combination of several tail pairs and labels allows the detection of DNA fragment by different fluorophores and increases the number of fragments that can be analyzed in one reaction. PCR products can be analyzed without any purification on a DNA sequencer for fragment detection and quantification. Finally, simple and easy calculations allow the detection of fragments with deletions or extra copies. The use of EOSAL-CNV allows simplifying and reducing costs in sample analysis for CNV detection.

Indexed as

DNA Copy Number VariationsPolymerase Chain ReactionCNV detectionGeneticsMethodologyPCR multiplex

Identifiers

PMID37041448
OpenAlexW4364856507

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.